Animal derived antibodies should be considered alongside convalescent human plasma to deliver treatments for COVID-19

Other

Abstract: Published data on the first 5,000 coronavirus patients to receive plasma shows promise in the United

Palabras claves:

Antibodies, covid19, hyper-immune sera, Plasma, therapy

Autores:

Ainsworth S., Pleass R.J., Stefanie K. Menzies

Fuentes:

scopus